This inventor holds 1 USPTO granted patent. Top assignee: Janssen Biopharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dinesh Gala: Innovator in Oligonucleotide Synthesis
Introduction
Dinesh Gala is a prominent inventor based in Monroe, CA (US). He has made significant contributions to the field of oligonucleotide synthesis, showcasing his expertise through innovative methods and techniques. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Dinesh Gala holds a patent for the "Synthesis of oligonucleotides and related compounds." This patent discloses methods of synthesizing oligonucleotides via new intermediates on a cleavable support having an azidomethyl moiety. The method involves multiple reaction cycles, which include sequential coupling of a nucleoside or oligonucleotide subunit on a cleavable support, capping, oxidation/thiolation, and deblocking. The orthogonal cleavage of the azidomethyl support while keeping all other protecting groups intact is a key feature of this method. This innovative approach can be utilized in both solid phase and liquid phase oligo synthesis, facilitating homogeneous reactions and efficient separations.
Career Highlights
Dinesh Gala is currently associated with Janssen Biopharma, Inc., where he continues to advance his research in oligonucleotide synthesis. His work has led to the development of novel intermediates that are useful in the synthesis of oligonucleotide conjugates. With a focus on improving synthesis methods, Gala's contributions are paving the way for advancements in the field.
Collaborations
Dinesh has collaborated with notable colleagues, including Minghong Zhong and Yi Jin. These collaborations have further enriched his research and have contributed to the success of his innovative projects.
Conclusion
Dinesh Gala's work in the synthesis of oligonucleotides represents a significant advancement in biotechnology. His innovative methods and collaborations highlight his commitment to pushing the boundaries of scientific research. His contributions will undoubtedly have a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile